Idiosyncrasies of Vitamin D Metabolism in the Green Iguana (Iguana iguana)
JB Bernard, OT Oftedal, DE Ullrey. 1996. Proceedings, Comparative Nutrition Society Symposium, pp. 11-14
The objective of these projects was to determine the effectiveness of oral and injectable supplementation of vitamin D3 as well as experimental UV-emitting lamps as means of improving the vitamin D status of captive green iguanas.
Serum levels of 25-hydroxyvitamin D for all animals were determined by the radiorecptor assay technique of Chen et al. (1990). Whole body radiographs, taken prior to and immediately after the experimental period, were used as a gross measure of skeletal calcification.
Project 1: Twenty-five green iguanas (11 adults, 14 juveniles) were each allotted by age and weight to one of five treatment groups. Animals receiving treatment 1 served as the control and were provided with no additional vitamin D and no UV lights. Iguanas on treatment 2 were given IM injections of vitamin D3 (cholecalciferol) at the rate of 1,000-3,000 IU/kg body weight at beginning of the study (day 0), and again on day 46. The initial injection was crystalline cholecalciferol (Sigma Chemicals #C-9756, St Louis, MO) in a glycerol suspension, and the subsequent injection was an emulsifiable base containing 10,000 IU cholecalciferol/ml in 95% ethanol (Henkel Corporation, LaGrange, IL). Animals in treatments 3 through 5 had exposure for 12 hours per day to a daylight phosphor lamp, a 35% Sylvania 2096 phosphor experimental lamp or a 100% Sylvania 2096 phosphor experimental lamp, respectively. The animals were able to regulate their distance from the lamp from 5 cm to 70 cm [2-28 in.] but were provided with no shaded area. Blood was collected from each animal on day 0, 27, 46, 67, 89, 166 and 204 for determination of 25-hydroxyvitamin D.
Project 2: Eight hatchling green iguanas, blocked by initial weight and whole body bone mineral concentration, were allotted to one of two treatment groups. On day 0, animals in treatment group 1 were administered an oral dose of vitamin D3 suspended in corn oil (34,000 IU/mI) at the rate of 0.25 µl (8.5 IU)/g body weight. Doses were administered to the closest µl using an adjustable Eppendorf ® micropipettor. Additionally, the animals on treatment 1 were exposed to General Electric Cool White fluorescent lamps for 12 hours daily.[a] Animals in treatment group 2 were given no supplemental vitamin D but were exposed to an experimental lamp, the Sylvania Experimental Reptile Light (modification of the 25% 2096 phosphor lamp with a color rendering index of at least 91 and a correlated color temperature of 5500°K), for 12 hours each day. All lamps were mounted 61 cm [24.4 in.] from the floor of the reptile enclosures. Although the iguanas were able to regulate their distance from the lamp, between 30 cm and 61 cm [12-24 in.], they were provided no completely shaded area. Blood samples were obtained from each animal on day 0, 7, 21 and 35 for determination of serum 25-hydroxyvitamin D.
Analyzed data for serum 25-hydroxyvitamin D are presented in Figures 1and 2. In Project 1, significant differences were not evident between the control treatment and the daylight treatment at any time (P> 0.05). Differences between the control treatment and the injection treatment were seen only at day 27 (P <0.005) and at day 67 (P <0.0003), each of which were approximately 3 weeks subsequent to vitamin D injections. Both the 35% and 100% 2096 treatments produced highly significant differences from other treatments at all sampling times after baseline (P <0.0001). In Project 2, baseline concentrations were not significantly different (P> 0.05) between treatments, nor were there significant differences between the oral dose treatment and the UV light treatment at 7 days (P> 0.05). By days 21 and 35, however, differences between the treatments were significant (P <0.004 and P <0.0007, respectively).
The iguanas on Project 1 demonstrated a serum response in 25-hydroxyvitamin D to both forms of injectable cholecalciferol. It appeared that the injection in the emulsified base produced a higher response in serum 25-hydroxyvitamin D concentrations and sustained elevated serum concentrations of this vitamin D metabolite for a longer period. Each injected dose was roughly equivalent to the total amount of cholecalciferol an iguana would consume in a diet containing 2,000 IU/kg in a 5-month period. Yet, serum concentrations were still significantly lower than those attained by exposure to UV light.
The percentage of 2096 phosphor was a significant factor in producing elevated levels of 25-hydroxyvitamin D in animals exposed to experimental lamps, with higher concentrations of this vitamin D metabolite associated with higher percentages of the phosphor. Serum concentrations of 25-hydroxyvitamin D in all animals exposed to the 2096 phosphor were maintained consistently in excess of 200 ng/ml, and ranged as high as 1,200 ng/ml.
In Project 2, all dosed animals exhibited a serum response to the oral cholecalciferol. The peak response in the absorption curve to this oral dose may have been missed due to the intervals between blood collections. However, by day 21 serum concentrations of 25-hydroxyvitamin D in the orally dosed iguanas already were on the decline. The amount of cholecalciferol administered to each animal (8.5 IU/g BW) was an extremely high dose, yet, serum concentrations of 25-hydroxyvitamin D were significantly lower than those attained by exposure to UV radiation. Serum concentrations of 25-hydroxyvitamin D in all animals exposed to the Experimental Reptile Light rose relatively rapidly, and were maintained after day 21 in excess of 330 ng/ml, ranging as high as 575 ng/mI.
Serum concentrations of 25-hydroxyvitamin D of the magnitude seen in these projects have not been reported in other species, but concentrations previously reported in captive green iguanas housed outdoors were > 400 ng/ml (Allen et al., 1994). There may be several potential problems associated with highly elevated serum concentrations of vitamin D metabolites. In those species which have been studied, concentrations such as those seen here, might be associated with pathology. However, no clinical signs or radiographic evidence of vitamin D toxicity were seen in these iguanas.[b]
To attain such extraordinary serum concentrations of 25-hydroxyvitamin D, the iguana must have a remarkable capacity to convert cutaneous precursors to previtamin D3. Additionally the thermal conversion of previtamin D3 to vitamin D3 also must be highly efficient. The regulation of cutaneous production of vitamin D3 precursors in human skin precludes excess conversion of previtamin D3 to vitamin D3 by shifting photoisomerization of previtamin D3 to its biologically inert isomers, lumisterol and tachysterol, in lieu of vitamin D3 (Holick et al., 1981 and Webb and Holick, 1988). The extraordinarily elevated concentrations of serum 25-hydroxyvitarnin D found in iguanas exposed daily for 12 hours to UV radiation may challenge the effectiveness of this method of regulation. It is quite possible, however, that if iguanas are provided with access to shaded areas, as they would be in the wild, they may regulate vitamin D production by behaviorally limiting their UV exposure.[c]
Further studies are necessary if the mechanism of vitamin D production and regulation in iguanas are to be identified. It is critical, however, to continue research with lamps such as the Sylvania Expeimetal Reptile Light to establish long term safety and effectiveness for maintaining the health of captive herpetofauna. It is obvious that any UV source identified for intended use with captive animals should support adequate vitamin D3 photobiogenesis without causing tissue damage or other adverse effects.
Allen, M. E., M. Bush, 0. T. Oftedal, R. Rosscoe, T. Walsh and M. F. Holick. 1994. Update on vitamin D and ultraviolet light in basking lizards. Pp.314-316, in: Proceedings of the American Association of Zoo Veterinarians, Pittsburgh.
Chen, T. C., A. K. Turner and M. F. Holick. 1990. Methods for the determination of circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem 1:315-319.
Holick, M. F., J. A. MacLaughlin and S. H. Doppelt. 1981. Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 211:590-593.
Webb, A. R. and M. F. Holick. 1988. The role of sunlight in the cutaneous production of vitamin D3. Ann Rev Nutr 8:375-399.
1 Comparative Nutrition Group, Perry, MI 48872
2 Department of Zoological Research, National Zoological Park, Smithsonian Institution, Washington D.C. 20008
3 Department of Animal Science, Michigan State University, East Lansing, MI 48824
b It is unknown which iguanas who were suffering from metabolic bone disease (MBD) at the start of the study were allocated to which groups. The use of oral and injectible D3 in the clinical management of MBD is known to be effective, temporarily increasing the serum D3 to kick-start, as it were, increased calcium uptake when the cause, or part of the cause, of the MBD, was due to inadequate UVB exposure. Given that wild green iguanas do not get the full brunt of the sun all day long, and that the amount of UV reaching them varies during the course of the day when they are exposed to full sun and partial shade, subjecting them to very high output UVB sources in captivity without providing shade results in their getting more UVB exposure than they do in the wild. The serum concentrations of iguanas kept under the VHO phosphor lamps was far in excess of that known to be dangerous in other species. The iguanas in the treatment groups exposed to the Sylvania 2096 lamps were exposed to them for just over six months; longer exposure periods are needed before any determination of D3 toxicity will be known. Symptoms of D3 toxicity are similar to those of MBD.
c The report mentions the "extraordinary serum concentrations" in the iguanas exposed to the UV lamps, and their "remarkable capacity to convert cutaneous precursors to previtamin D3." In humans, the conversion process precludes conversion of too much D3. This is one case where using human biology as a model doesn't work: humans spend most of their time outdoors with most of their bodies covered by clothing. Vitamin D deficiencies have been common enough to result in many foods being fortified with D. It is thought that iguanas have a similar mechanism at play, that their bodies will not convert any more previtamin D3 to vitamin D3 than their body needs to maintain proper functioning. One would then expect to see a level serum 25-hydroxyvitamin D in their blood. That many of the test iguanas had highly elevated levels indicates that this is not the case. In the wild, when iguanas retreat to shaded areas to cool down, they are also reducing their exposure to UVB. If one chooses to use the newer VHO UVB fluorescent tube or lights in their iguana's environments, one should make sure to provide shade areas for the iguana to retreat to - and make sure the iguana is in fact thermoregulating by spending time in the shade. If the iguana remains exposed to the VHO source for prolonged periods of time, or never uses the shaded area, consider switching to one of the low output tubes known to be safe and effective (such as DuroTest's Vita-Lite® or Zoo Med's Repti-Sun®) or get the iguana's serum levels of D, calcium and phosphorous checked regularly for the first several years to make sure there is no sign of D toxicity.
Need to update a veterinary or herp society/rescue listing?
|Clean/Disinfect||Green Iguanas & Cyclura||Kids||Prey||Veterinarians|
|Home||About Melissa Kaplan||CND||Lyme Disease||Zoonoses|
|Help Support This Site||Emergency Preparedness|
© 1994-2013 Melissa Kaplan or as otherwise noted by other authors of articles on this site